Rep. Gilbert Ray Cisneros, Jr. sold Airbnb (ABNB)
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31) · $1K–$15K · traded Jan 24, 2025
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Jan 24, 2025
- Disclosed
- Feb 11, 2025
- Days to disclose
- 18
- Asset type
- Stock
- As filed
- Airbnb, Inc. - Class A Common Stock
- Industry
- Travel Services · Consumer Cyclical
Other trades in this filing
All of Cisneros's trades →- Feb 11, 2025$1K–$15K
Sold (partial) ICF International ICFI
$1K–$15K · Traded Feb 3, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$250K–$500K
$250K–$500K · Traded Jan 31, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$50K–$100K
Bought Hawaiian Electric Industries HE
$50K–$100K · Traded Jan 31, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$15K–$50K
Bought CACI International CACI
$15K–$50K · Traded Jan 31, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Bought Intuitive Surgical ISRG
$1K–$15K · Traded Jan 30, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
$1K–$15K · Traded Jan 30, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Bought SpringWorks Therapeutics SWTX
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Bought U.S. Physical Therapy USPH
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Bought Crinetics Pharmaceuticals CRNX
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
$1K–$15K · Traded Jan 28, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Bought Willis Towers Watson Public Limited Company WTW
$1K–$15K · Traded Jan 28, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$15K–$50K
Sold (partial) Lam Research LRCX
$15K–$50K · Traded Jan 28, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
$1K–$15K · Traded Jan 24, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Sold The J. M. Smucker Company SJM
$1K–$15K · Traded Jan 24, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Sold (partial) Quest Diagnostics DGX
$1K–$15K · Traded Jan 24, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
Sold (partial) Mondelez International MDLZ
$1K–$15K · Traded Jan 24, 2025 · disclosed Feb 11, 2025
- Feb 11, 2025$1K–$15K
$1K–$15K · Traded Jan 24, 2025 · disclosed Feb 11, 2025
Recent Congress trades in ABNB
- Aug 14, 2026$1K–$15K
Rep. Michael Guest (R-MS-3)
$1K–$15K · Traded Dec 16, 2025 · disclosed Aug 14, 2026 · Spouse · filed 241 days later
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Aug 26, 2025 · disclosed Sep 12, 2025 · Dependent
- Apr 28, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed Apr 28, 2025
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Jan 15, 2025$1K–$15K
Rep. William R. Keating (D-MA-9)
$1K–$15K · Traded Jan 7, 2025 · disclosed Jan 15, 2025
- Aug 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jul 9, 2024 · disclosed Aug 15, 2024 · Joint
- Jul 9, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 26, 2024 · disclosed Jul 9, 2024 · Joint
Company context for ABNB
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
ABNB: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
ABNB: Financial results
Filed 8-K for an event or period dated 2026-11-05. Financial results.
Rescission of Rule 14a-8's Federal Regulation of Shareholder Proposals and Amendments to Rule 14a-4
The Securities and Exchange Commission ("Commission") is proposing to rescind Rule 14a-8 under the Securities Exchange Act of 1934 ("Exchange Act") and leave determinations about the role of shareholder proposals to State law and company governing documents. The Commission also is proposing to amend Rule 14a-4 under the Exchange Act to expand the circumstances under which a company may exercise, with respect to proxies it receives, discretionary voting authority on proposals that will be presented at a shareholder meeting but not included in the company's proxy materials. At the same time, the proposed amendments to Rule 14a-4 would provide shareholders with the means to elect to prevent the company from exercising such authority with respect to their individual shares.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.